T-cell responses of vaccinated cancer patients

被引:73
作者
Coulie, PG [1 ]
van der Bruggen, P [1 ]
机构
[1] Univ Louvain, Cellular Genet Unit, Christian Duve Inst Cellular Pathol, B-1200 Brussels, Belgium
关键词
D O I
10.1016/S0952-7915(03)00009-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Following vaccination with defined tumor antigens that are recognized by T cells, a small proportion of cancer patients display tumor regressions. Several reports describe anti-vaccine T-cell responses, evaluated with a variety of methods, for example, by assessing T-cell function or expression of specific TCR. However, a correlation between these T-cell responses and the tumor regressions has not yet been established. It appears that some patients display tumor regression with an unexpectedly low frequency of anti-vaccine T cells.
引用
收藏
页码:131 / 137
页数:7
相关论文
共 65 条
[41]  
Mortarini R, 2000, CANCER RES, V60, P3559
[42]   Reevaluation of the cellular immune response in breast cancer patients vaccinated with MUC1 [J].
Musselli, C ;
Ragupathi, G ;
Gilewski, T ;
Panageas, KS ;
Spinat, Y ;
Livingston, PO .
INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (05) :660-667
[43]   Rapid induction of specific cytotoxic T lymphocytes against melanoma-associated antigens by a recombinant vaccinia virus vector expressing multiple immunodominant epitopes and costimulatory molecules in vivo [J].
Oertli, D ;
Marti, WR ;
Zajac, P ;
Noppen, C ;
Kocher, T ;
Padovan, E ;
Adamina, M ;
Schumacher, R ;
Harder, F ;
Heberer, M ;
Spagnoli, GC .
HUMAN GENE THERAPY, 2002, 13 (04) :569-575
[44]   Short-term kinetics of tumor antigen expression in response to vaccination [J].
Ohnmacht, GA ;
Wang, E ;
Mocellin, S ;
Abati, A ;
Filie, A ;
Fetsch, P ;
Riker, AI ;
Kammula, US ;
Rosenberg, SA ;
Marincola, FM .
JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1809-1820
[45]  
Pittet MJ, 2001, CLIN CANCER RES, V7, p796S
[46]   Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection [J].
Reignat, S ;
Webster, GJM ;
Brown, D ;
Ogg, GS ;
King, A ;
Seneviratne, SL ;
Dusheiko, G ;
Williams, R ;
Maini, MK ;
Bertoletti, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (09) :1089-1101
[47]   Quantitation of antigen-reactive T cells in peripheral blood by IFNγ-ELISPOT assay and chromium-release assay:: a four-centre comparative trial [J].
Scheibenbogen, C ;
Romero, P ;
Rivoltini, L ;
Herr, W ;
Schmittel, A ;
Cerottini, JC ;
Woelfel, T ;
Eggermont, AMM ;
Keilholz, U .
JOURNAL OF IMMUNOLOGICAL METHODS, 2000, 244 (1-2) :81-89
[48]   Recombinant vaccinia virus encoding human MUC1 and IL2 as immunotherapy in patients with breast cancer [J].
Scholl, SM ;
Balloul, JM ;
Le Goc, G ;
Bizouarne, N ;
Schatz, C ;
Kieny, MP ;
von Mensdorff-Pouilly, S ;
Vincent-Salomon, A ;
Deneux, L ;
Tartour, E ;
Fridman, W ;
Pouillart, P ;
Acres, B .
JOURNAL OF IMMUNOTHERAPY, 2000, 23 (05) :570-580
[49]   Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells [J].
Schuler-Thurner, B ;
Dieckmann, D ;
Keikavoussi, P ;
Bender, A ;
Maczek, C ;
Jonuleit, H ;
Röder, C ;
Haendle, I ;
Leisgang, W ;
Dunbar, R ;
Cerundolo, V ;
von den Driesch, P ;
Knop, J ;
Bröcker, EB ;
Enk, A ;
Kämpgen, E ;
Schuler, G .
JOURNAL OF IMMUNOLOGY, 2000, 165 (06) :3492-3496
[50]   Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells [J].
Schuler-Thurner, B ;
Schultz, ES ;
Berger, TG ;
Weinlich, G ;
Ebner, S ;
Woerl, P ;
Bender, A ;
Feuerstein, B ;
Fritsch, PO ;
Romani, N ;
Schuler, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (10) :1279-1288